EVP Finance CFO · REGENERON PHARMACEUTICALS, INC. · Common Stock
Side
F
Value
$4.03M
Shares
4,243
Price
$950.5
Executed
Nov 2, 2026
Disclosed
Nov 4, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 2 executedNov 4, 2026 disclosed
REGN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+18 / 25
$4.0M reported value · 24.2% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Fenimore Christopher R. filed this Form 4 reporting a tax withholding of REGN on Nov 2, 2026. It became public on Nov 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP Finance CFO
Fenimore Christopher R.cik:0001697422
Issuer
REGENERON PHARMACEUTICALS, INC.cik:0000872589
Revision history · 0
No field has changed since this record was first ingested.
